SCHEMBL6974147

SCHEMBL6974147

CCOC(=O)[C@](C)(N)Cc1ccc(Br)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 1/20 0.48
BLM P54132 2/20 0.45
CYP1A2 P05177 4/20 0.45
ALDH1A1 P00352 4/20 0.45
LMNA P02545 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
NPSR1 Q6W5P4 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
MAPT P10636 4/20 0.42
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42
MAPK1 P28482 2/20 0.42
S1PR4 O95977 1/20 0.42
S1PR1 P21453 1/20 0.42
RECQL P46063 3/20 0.41
KDM4E B2RXH2 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5205928 1.00 MMP8 (0.48) MMP8BLMCYP1A2ALDH1A1LMNA
SCHEMBL5205923 1.00 MMP8 (0.48) MMP8BLMCYP1A2ALDH1A1LMNA
SCHEMBL9386398 0.86 BLM (0.63) MMP8BLMCYP1A2ALDH1A1SMN1; SMN2
SCHEMBL9386400 0.86 BLM (0.63) MMP8BLMCYP1A2ALDH1A1SMN1; SMN2
SCHEMBL7362869 0.85 MMP8 (0.59) MMP8CYP1A2ALDH1A1LMNASMN1; SMN2
SCHEMBL1773480 0.84 CYP3A4 (0.55) MMP8BLMCYP1A2ALDH1A1LMNA
SCHEMBL4299713 0.84 CYP3A4 (0.55) MMP8BLMCYP1A2ALDH1A1LMNA
SCHEMBL1831636 0.84 MMP8 (0.61) MMP8BLMALDH1A1LMNASMN1; SMN2
SCHEMBL10684512 0.84 MMP8 (0.61) MMP8BLMALDH1A1LMNASMN1; SMN2
SCHEMBL7699138 0.84 BLM (0.47) BLMCYP1A2ALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE38132-E1 Phenylpyrrolidines, phenylimidazolidines,3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2003-06-03 US disclosed
EP-0966447-B1 SMALL MOLECULES USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASE BOEHRINGER INGELHEIM PHARMA (US) 2003-03-05 EP disclosed
US-6355664-B1 ADULT RESPIRATORY DISTRESS SYNDROME AND CARDIOVASCULAR DISORDERS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2002-03-12 US disclosed
US-6353013-B1 ANTIINFLAMMATORY AGENTS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2002-03-05 US disclosed
US-6350763-B1 AND IMMUNE CELL-MEDIATED DISEASES; SELECTIVELY ANTAGONIZE THE BINDING OF THE CAMS TO THE LEUKOINTEGRINS; BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2002-02-26 US disclosed
WO-2001007048-A1 SMALL MOLECULES USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASE BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-02-01 WO disclosed
US-6043376-A Synthesis of alpha-methyl, alpha-substituted amino acids BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2000-03-28 US disclosed
EP-0966447-A1 SMALL MOLECULES USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASE BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1999-12-29 EP disclosed
WO-1998039303-A1 SMALL MOLECULES USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASE BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1998-09-11 WO disclosed